Doximity, Inc. (DOCS)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Doximity, Inc. (DOCS) ist im Healthcare-Sektor taetig, zuletzt notiert bei $23.69 mit einer Marktkapitalisierung von 5B. Die Aktie erzielt 52/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 8. Feb. 2026Doximity, Inc. (DOCS) Gesundheitswesen & Pipeline-Uebersicht
Doximity is revolutionizing healthcare communication with its cloud-based platform, connecting medical professionals for enhanced collaboration, patient care, and career development, while boasting impressive financials like a 37.5% profit margin and 89.7% gross margin, making it a compelling investment in the digital health space.
Investmentthese
Doximity presents a notable research candidate due to its dominant position in the medical professional networking space and its high-margin business model. The company's platform is deeply embedded in the daily workflows of physicians, creating a strong network effect and high barriers to entry. With a market capitalization of $5.21 billion and a P/E ratio of 21.72, Doximity demonstrates financial strength and growth potential. Key value drivers include continued expansion of its user base, increased adoption of its telehealth and advertising solutions, and strategic partnerships with healthcare systems and pharmaceutical companies. The company's impressive gross margin of 89.7% and profit margin of 37.5% highlight its operational efficiency and pricing power. Upcoming catalysts include the further integration of AI-powered tools into the platform and expansion into new medical specialties, solidifying its position as a leader in healthcare technology.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $5.21 billion, reflecting strong investor confidence in Doximity's market position and growth prospects.
- P/E ratio of 21.72, indicating a premium valuation based on its earnings potential and growth trajectory.
- High gross margin of 89.7%, showcasing the company's efficient cost structure and pricing power in the healthcare technology market.
- Profit margin of 37.5%, demonstrating strong profitability and effective management of operating expenses.
- Beta of 1.39, suggesting higher volatility compared to the market, potentially offering greater returns but also increased risk.
Wettbewerber & Vergleichsunternehmen
Staerken
- Dominant position in the medical professional networking space.
- High gross and profit margins.
- Strong network effect and user engagement.
- Comprehensive platform with a wide range of features.
Schwaechen
- Reliance on advertising revenue, which can be cyclical.
- Limited geographic diversification, primarily focused on the United States.
- Potential for increased competition from larger technology companies.
- Vulnerable to changes in healthcare regulations and policies.
Katalysatoren
- Ongoing: Continued expansion of telehealth services driving increased user engagement and revenue.
- Upcoming: Integration of AI-powered tools to enhance platform functionality and improve user experience.
- Ongoing: Strategic partnerships with healthcare systems to expand reach and market penetration.
- Upcoming: Launch of new features and services tailored to specific medical specialties.
Risiken
- Potential: Increased competition from larger technology companies entering the healthcare market.
- Potential: Data security and privacy breaches compromising user data and damaging reputation.
- Ongoing: Changes in healthcare regulations and reimbursement policies impacting revenue streams.
- Potential: Economic downturn leading to reduced advertising spending from pharmaceutical manufacturers.
Wachstumschancen
- Expansion of Telehealth Services: Doximity has the opportunity to further expand its telehealth offerings, capitalizing on the increasing demand for virtual patient visits. The telehealth market is projected to reach $285.7 billion by 2027, presenting a significant growth opportunity for Doximity. By enhancing its virtual visit platform and integrating it with other clinical workflows, Doximity can attract more physicians and patients, driving revenue growth and solidifying its position in the telehealth market.
- Increased Adoption of Advertising Solutions: Doximity can leverage its extensive network of medical professionals to drive increased adoption of its advertising solutions among pharmaceutical manufacturers and healthcare systems. The digital health advertising market is estimated to be worth billions of dollars annually. By offering targeted advertising campaigns and demonstrating the effectiveness of its platform in reaching physicians, Doximity can capture a larger share of this market and generate substantial revenue growth.
- Strategic Partnerships with Healthcare Systems: Doximity can forge strategic partnerships with healthcare systems to integrate its platform into their existing workflows and electronic health record systems. These partnerships can provide Doximity with access to a larger pool of physicians and patients, driving user growth and increasing platform engagement. By collaborating with healthcare systems, Doximity can also develop customized solutions that address their specific needs, further strengthening its competitive advantage.
- Integration of AI-Powered Tools: Doximity can integrate AI-powered tools into its platform to enhance its functionality and improve the user experience. AI can be used to automate tasks, personalize content, and provide insights to physicians, making the platform more valuable and engaging. By leveraging AI, Doximity can differentiate itself from competitors and attract more users, driving revenue growth and solidifying its position as a leader in healthcare technology.
- Expansion into New Medical Specialties: Doximity can expand its platform to include new medical specialties, broadening its reach and increasing its user base. By tailoring its platform to the specific needs of different specialties, Doximity can attract more physicians and generate additional revenue streams. This expansion can be achieved through targeted marketing campaigns, partnerships with medical associations, and the development of specialty-specific content and tools.
Chancen
- Expansion into new medical specialties and geographic markets.
- Increased adoption of telehealth and virtual care solutions.
- Strategic partnerships with healthcare systems and pharmaceutical companies.
- Integration of AI-powered tools to enhance platform functionality.
Risiken
- Increased competition from existing and new players in the healthcare technology market.
- Data security and privacy breaches.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn impacting advertising spending.
Wettbewerbsvorteile
- Strong network effect due to its large and engaged user base of medical professionals.
- High switching costs for users who have integrated the platform into their daily workflows.
- Proprietary technology and data analytics capabilities.
- Established brand reputation and trust within the medical community.
Ueber DOCS
Doximity, Inc., initially founded as 3MD Communications, Inc. before rebranding in June 2010, emerged in 2010 with a vision to transform how medical professionals connect and collaborate. Headquartered in San Francisco, Doximity has established itself as a leading cloud-based digital platform tailored for the specific needs of physicians and healthcare providers across the United States. The platform offers a suite of tools designed to streamline workflows, enhance communication, and facilitate continuous learning. Doximity's core offerings include secure messaging for HIPAA-compliant communication, a virtual patient visit platform for telehealth consultations, and a comprehensive medical news feed to keep members updated on the latest research and clinical advancements. Furthermore, the platform provides career management resources, enabling physicians to explore job opportunities and advance their professional development. Doximity primarily serves pharmaceutical manufacturers and healthcare systems, offering targeted advertising and marketing solutions through its extensive network of medical professionals. With 827 employees, Doximity continues to innovate and expand its platform to meet the evolving needs of the healthcare industry.
Was das Unternehmen tut
- Provides a cloud-based digital platform for medical professionals.
- Enables collaboration among physicians and healthcare providers.
- Facilitates coordination of patient care through secure messaging and virtual visits.
- Offers a virtual patient visit platform for telehealth consultations.
- Delivers up-to-date medical news and research to its members.
- Provides career management resources for physicians.
- Connects pharmaceutical manufacturers and healthcare systems with medical professionals for targeted advertising.
Geschaeftsmodell
- Subscription fees from healthcare systems for access to the platform and its features.
- Advertising revenue from pharmaceutical manufacturers targeting physicians.
- Revenue from virtual patient visit platform usage.
- Data analytics and insights services for healthcare organizations.
Branchenkontext
Doximity operates within the rapidly growing healthcare information services industry, driven by the increasing adoption of digital health technologies and the need for improved communication and collaboration among healthcare professionals. The market is characterized by intense competition, with companies vying for market share in telehealth, electronic health records, and medical networking. Doximity's focus on providing a comprehensive platform specifically tailored for physicians gives it a competitive edge. The industry is expected to continue its growth trajectory, fueled by factors such as the aging population, rising healthcare costs, and advancements in technology.
Wichtige Kunden
- Physicians and other medical professionals.
- Pharmaceutical manufacturers.
- Healthcare systems.
- Medical associations.
Finanzdaten
Chart & Info
Doximity, Inc. (DOCS) Aktienkurs: $23.69 (-0.62, -2.55%)
Aktuelle Nachrichten
-
Doximity, Inc. (NYSE:DOCS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
defenseworld.net · 26. März 2026
-
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now?
zacks.com · 25. März 2026
-
Hims & Hers Expands Integrated Digital Healthcare Ecosystem
Yahoo! Finance: DOCS News · 23. März 2026
-
Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target
Yahoo! Finance: DOCS News · 20. März 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer DOCS.
Kursziele
Konsens-Kursziel: $46.16
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von DOCS auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
Aktuelle Nachrichten
Doximity, Inc. (NYSE:DOCS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now?
Hims & Hers Expands Integrated Digital Healthcare Ecosystem
Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target
Doximity, Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for DOCS?
Doximity, Inc. (DOCS) currently holds an AI score of 52/100, indicating moderate score. The stock trades at a P/E of 18.6x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $46.16 (+95% from $23.69). Key strength: Dominant position in the medical professional networking space.. Primary risk to monitor: Potential: Increased competition from larger technology companies entering the healthcare market.. This is not financial advice.
How frequently does DOCS data refresh on this page?
DOCS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DOCS's recent stock price performance?
Recent price movement in Doximity, Inc. (DOCS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $46.16 implies 95% upside from here. Notable catalyst: Dominant position in the medical professional networking space.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DOCS overvalued or undervalued right now?
Determining whether Doximity, Inc. (DOCS) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 18.6. Analysts target $46.16 (+95% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DOCS?
Before investing in Doximity, Inc. (DOCS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding DOCS to a portfolio?
Potential reasons to consider Doximity, Inc. (DOCS) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Dominant position in the medical professional networking space.. Additionally: High gross and profit margins.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of DOCS?
Yes, most major brokerages offer fractional shares of Doximity, Inc. (DOCS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track DOCS's earnings and financial reports?
Doximity, Inc. (DOCS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for DOCS earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on available data as of 2026-02-08. Market conditions and company performance may change over time.